Design Therapeutics Ownership 2024 | Who Owns Design Therapeutics Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

117.73%

Insider Ownership

36.45%

Retail Ownership

-54.18%

Institutional Holders

308.00

Design Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PRICE T ROWE ASSOCIATES INC /MD/12.90%0.08%7,289,325-313,247-4.12%705,899,000Jun 30, 2024
DURABLE CAPITAL PARTNERS LP6.12%2.75%3,455,887-178,950-4.92%334,668,097Jun 30, 2024
VANGUARD GROUP INC5.65%0.01%3,193,79256,1551.79%309,286,817Jun 30, 2024
CONESTOGA CAPITAL ADVISORS, LLC5.52%4.52%3,116,10966,6452.19%301,763,996Jun 30, 2024
JARISLOWSKY, FRASER LTD5.12%1.70%2,890,232-438,988-13.19%279,972,413Jun 30, 2024
FIERA CAPITAL CORP4.53%0.78%2,558,83181,2633.28%248,024,162Jun 30, 2024
PRIMECAP MANAGEMENT CO/CA/3.96%0.16%2,238,553-51,200-2.24%216,781,473Jun 30, 2024
MACKENZIE FINANCIAL CORP3.78%0.31%2,134,22891,3014.47%206,807,458Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.3.63%0.83%2,050,757185,5399.95%198,722,284Jun 30, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.3.00%0.10%1,697,151-379,505-18.27%164,353,000Jun 30, 2024
BANK OF MONTREAL /CAN/2.74%0.04%1,545,02721,1051.38%147,434,474Jun 30, 2024
GENEVA CAPITAL MANAGEMENT LLC2.58%2.57%1,457,657-810-0.06%141,159,486Jun 30, 2024
INVESCO LTD.2.49%0.03%1,408,910-121,507-7.94%136,438,844Jun 30, 2024
FRANKLIN RESOURCES INC2.35%0.04%1,327,13997,9817.97%128,522,469Jun 30, 2024
CONGRESS ASSET MANAGEMENT CO /MA2.16%0.85%1,221,5881,221,588100.00%118,298,614Jun 30, 2024
NORGES BANK1.99%0.02%1,123,6331,123,633100.00%108,882,191Jun 30, 2024
RIVERBRIDGE PARTNERS LLC1.61%1.20%910,909-65,704-6.73%88,212,443Jun 30, 2024
TD ASSET MANAGEMENT INC1.40%0.07%792,280-28,152-3.43%76,744,460Jun 30, 2024
ROYAL BANK OF CANADA1.23%0.02%696,923-37,241-5.07%67,489,000Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC1.22%0.02%690,479690,479100.00%66,865,987Jun 30, 2024

Design Therapeutics's largest institutional shareholder is PRICE T ROWE ASSOCIATES INC /MD/, holding 12.90% of the company's total share outstanding, currently valued at $705.90M. The top 10 institutional shareholders own together 54.21% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ZENO EQUITY PARTNERS LLP0.47%6.86%266,2761,6960.64%25,786,168Jun 30, 2024
CONESTOGA CAPITAL ADVISORS, LLC5.52%4.52%3,116,10966,6452.19%301,763,996Jun 30, 2024
HERALD INVESTMENT MANAGEMENT LTD0.41%3.65%230,000-10,000-4.17%22,243,300Jun 30, 2024
SUMMIT CREEK ADVISORS LLC0.46%3.43%258,254-57,736-18.27%25,009,317Jun 30, 2024
APERTURE INVESTORS, LLC0.42%3.34%236,27423,26210.92%22,894,201Jun 30, 2024
DURABLE CAPITAL PARTNERS LP6.12%2.75%3,455,887-178,950-4.92%334,668,097Jun 30, 2024
GENEVA CAPITAL MANAGEMENT LLC2.58%2.57%1,457,657-810-0.06%141,159,486Jun 30, 2024
TRIASIMA PORTFOLIO MANAGEMENT INC.0.45%2.25%253,849120,32590.11%24,583,681Jun 30, 2024
PEMBROKE MANAGEMENT, LTD0.22%2.24%125,984-4,232-3.25%16,699,179Jun 30, 2024
MINICHMACGREGOR WEALTH MANAGEMENT, LLC0.14%1.89%79,9547,89710.96%7,742,745Jun 30, 2024
GRANDEUR PEAK GLOBAL ADVISORS, LLC0.41%1.79%230,82520,3709.68%22,366,698Jun 30, 2024
JARISLOWSKY, FRASER LTD5.12%1.70%2,890,232-438,988-13.19%279,972,413Jun 30, 2024
PREMIER FUND MANAGERS LTD0.73%1.61%411,419-39,700-8.80%40,039,000Jun 30, 2024
ATIVO CAPITAL MANAGEMENT LLC0.02%1.38%13,770-200-1.43%1,333,485Jun 30, 2024
NBW CAPITAL LLC0.13%1.36%71,443-66-0.09%6,918,540Jun 30, 2024
RIVERBRIDGE PARTNERS LLC1.61%1.20%910,909-65,704-6.73%88,212,443Jun 30, 2024
ADDENDA CAPITAL INC.0.38%1.12%215,260-10,930-4.83%28,532,713Jun 30, 2024
REDWOOD INVESTMENTS, LLC0.06%1.01%35,2738992.62%2,968,340Jun 30, 2024
NICHOLAS INVESTMENT PARTNERS, LP0.16%0.93%92,2827660.84%8,936,589Jun 30, 2024
YORKTOWN MANAGEMENT & RESEARCH CO INC0.01%0.85%8,200--794,088Jun 30, 2024

The largest Design Therapeutics shareholder by % of total assets is ZENO EQUITY PARTNERS LLP. The company owns 266.28K shares of Design Therapeutics (DSGN), representing 6.86% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CONGRESS ASSET MANAGEMENT CO /MA2.16%0.85%1,221,5881,221,588100.00%118,298,614Jun 30, 2024
NORGES BANK1.99%0.02%1,123,6331,123,633100.00%108,882,191Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC1.22%0.02%690,479690,479100.00%66,865,987Jun 30, 2024
BLACKROCK INC.1.00%0.00%566,210213,67360.61%54,831,776Jun 30, 2024
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC0.38%0.05%212,806212,806100.00%20,608,133Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.3.63%0.83%2,050,757185,5399.95%198,722,284Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.31%0.00%176,457176,457100.00%17,093,167Jun 30, 2024
AEGON ASSET MANAGEMENT UK PLC0.33%0.25%184,147160,141667.09%17,605,000Jun 30, 2024
CONGRESS WEALTH MANAGEMENT LLC / DE /0.26%0.23%147,943147,943100.00%14,326,795Jun 30, 2024
TRIASIMA PORTFOLIO MANAGEMENT INC.0.45%2.25%253,849120,32590.11%24,583,681Jun 30, 2024
HANTZ FINANCIAL SERVICES, INC.0.19%0.20%108,456108,456100.00%10,503,000Jun 30, 2024
FRANKLIN RESOURCES INC2.35%0.04%1,327,13997,9817.97%128,522,469Jun 30, 2024
AMERICAN CENTURY COMPANIES INC0.43%0.01%243,98596,43165.35%23,639,642Jun 30, 2024
MACKENZIE FINANCIAL CORP3.78%0.31%2,134,22891,3014.47%206,807,458Jun 30, 2024
ENVESTNET ASSET MANAGEMENT INC0.44%0.01%250,66586,99853.16%24,274,399Jun 30, 2024
MACQUARIE GROUP LTD0.56%0.04%318,10784,02935.90%30,805,000Jun 30, 2024
FIERA CAPITAL CORP4.53%0.78%2,558,83181,2633.28%248,024,162Jun 30, 2024
DF DENT & CO INC0.39%0.27%218,59571,44448.55%21,168,696Jun 30, 2024
SEGALL BRYANT & HAMILL, LLC0.77%0.74%432,94569,60219.16%41,926,394Jun 30, 2024
CONESTOGA CAPITAL ADVISORS, LLC5.52%4.52%3,116,10966,6452.19%301,763,996Jun 30, 2024

As of Jun 30 2024, Design Therapeutics's largest institutional buyer is CONGRESS ASSET MANAGEMENT CO /MA. The company purchased 1.22M stocks of DSGN, valued at $118.30M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.08%0.05%611,830-633,322-50.86%59,280,000Jun 30, 2024
JARISLOWSKY, FRASER LTD5.12%1.70%2,890,232-438,988-13.19%279,972,413Jun 30, 2024
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.3.00%0.10%1,697,151-379,505-18.27%164,353,000Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/12.90%0.08%7,289,325-313,247-4.12%705,899,000Jun 30, 2024
GOLDMAN SACHS GROUP INC0.69%0.01%391,940-213,087-35.22%37,955,469Jun 30, 2024
DURABLE CAPITAL PARTNERS LP6.12%2.75%3,455,887-178,950-4.92%334,668,097Jun 30, 2024
SUMITOMO MITSUI TRUST HOLDINGS, INC.----166,646-100.00%-Jun 30, 2024
LORD, ABBETT & CO. LLC1.06%0.19%600,396-164,256-21.48%58,143,000Jun 30, 2024
MAN GROUP PLC0.14%0.02%76,859-124,630-61.85%7,445,210Jun 30, 2024
GRANITE INVESTMENT PARTNERS, LLC0.37%0.84%210,466-122,441-36.78%20,381,527Jun 30, 2024
INVESCO LTD.2.49%0.03%1,408,910-121,507-7.94%136,438,844Jun 30, 2024
BANK OF NOVA SCOTIA0.80%0.09%453,472-79,786-14.96%43,933,550Jun 30, 2024
RIVERBRIDGE PARTNERS LLC1.61%1.20%910,909-65,704-6.73%88,212,443Jun 30, 2024
WASATCH ADVISORS LP0.72%0.21%404,873-64,297-13.70%39,232,970Jun 30, 2024
CIBC WORLD MARKET INC.0.14%0.02%77,764-64,062-45.17%7,536,000Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.65%0.06%366,200-63,900-14.86%35,462,808Jun 30, 2024
NORTHERN TRUST CORP0.26%0.00%145,927-63,848-30.44%14,131,571,000Jun 30, 2024
SUMMIT CREEK ADVISORS LLC0.46%3.43%258,254-57,736-18.27%25,009,317Jun 30, 2024
MARYLAND STATE RETIREMENT & PENSION SYSTEM----57,628-100.00%-Jun 30, 2024
JANUS HENDERSON GROUP PLC1.12%0.03%633,522-55,244-8.02%61,368,591Jun 30, 2024

As of Jun 30 2024, Design Therapeutics's biggest institutional seller is ARROWSTREET CAPITAL, LIMITED PARTNERSHIP. The company sold -0.63M shares of DSGN, valued at $59.28M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CONGRESS ASSET MANAGEMENT CO /MA2.16%0.85%1,221,5881,221,588100.00%118,298,614Jun 30, 2024
NORGES BANK1.99%0.02%1,123,6331,123,633100.00%108,882,191Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC1.22%0.02%690,479690,479100.00%66,865,987Jun 30, 2024
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC0.38%0.05%212,806212,806100.00%20,608,133Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.31%0.00%176,457176,457100.00%17,093,167Jun 30, 2024
CONGRESS WEALTH MANAGEMENT LLC / DE /0.26%0.23%147,943147,943100.00%14,326,795Jun 30, 2024
HANTZ FINANCIAL SERVICES, INC.0.19%0.20%108,456108,456100.00%10,503,000Jun 30, 2024
CALAMOS ADVISORS LLC0.06%0.01%33,70633,706100.00%3,264,089Jun 30, 2024
TOWNSQUARE CAPITAL LLC0.05%0.04%27,67827,678100.00%2,680,337Jun 30, 2024
PCJ INVESTMENT COUNSEL LTD.0.04%0.85%21,08021,080100.00%2,041,723Jun 30, 2024
AVANTAX ADVISORY SERVICES, INC.0.03%0.01%14,98514,985100.00%1,451,147Jun 30, 2024
0.02%0.05%10,19210,192100.00%974,434Jun 30, 2024
APG ASSET MANAGEMENT N.V.0.02%0.00%9,8009,800100.00%885,745Jun 30, 2024
MOUNT YALE INVESTMENT ADVISORS, LLC0.01%0.06%8,2338,233100.00%797,284Jun 30, 2024
ATRIA INVESTMENTS, INC0.01%0.01%6,3376,337100.00%613,675Jun 30, 2024
WALLEYE CAPITAL LLC0.01%0.00%5,7005,700100.00%551,988Jun 30, 2024
ELLSWORTH ADVISORS, LLC0.01%0.15%5,4405,440100.00%526,810Jun 30, 2024
CI PRIVATE WEALTH, LLC0.01%0.00%5,2765,276100.00%510,928Jun 30, 2024
MML INVESTORS SERVICES, LLC0.01%0.00%4,9224,922100.00%477,000Jun 30, 2024
PARK AVENUE SECURITIES LLC0.01%0.01%4,4884,488100.00%435,000Jun 30, 2024
GUGGENHEIM CAPITAL LLC0.01%0.00%4,1004,100100.00%397,161Jun 30, 2024
SHEETS SMITH WEALTH MANAGEMENT0.01%0.05%3,9743,974100.00%384,842Jun 30, 2024
CYNOSURE MANAGEMENT, LLC0.01%0.06%3,9693,969100.00%384,527Jun 30, 2024
PORTSIDE WEALTH GROUP, LLC0.01%0.07%3,7923,792100.00%367,217Jun 30, 2024
ORION PORTFOLIO SOLUTIONS, LLC0.01%0.00%3,7693,769100.00%364,990Jun 30, 2024
LRT CAPITAL MANAGEMENT, LLC0.01%0.33%3,6413,641100.00%352,594Jun 30, 2024
LEGACY WEALTH ASSET MANAGEMENT, LLC0.01%0.10%3,6343,634100.00%351,917Jun 30, 2024
NORDEN GROUP LLC0.01%0.07%3,6043,604100.00%349,012Jun 30, 2024
ALLIANCE WEALTH ADVISORS, LLC /UT0.01%0.10%3,4543,454100.00%334,485Jun 30, 2024
WEDBUSH SECURITIES INC0.01%0.01%3,3943,394100.00%329,000Jun 30, 2024
CANANDAIGUA NATIONAL BANK & TRUST CO0.01%0.03%3,0473,047100.00%295,071Jun 30, 2024
ASCENT GROUP, LLC0.01%0.02%2,8442,844100.00%275,413Jun 30, 2024
KNOLLWOOD INVESTMENT ADVISORY, LLC0.00%0.03%2,6002,600100.00%251,784Jun 30, 2024
ATRIA WEALTH SOLUTIONS, INC.0.00%0.00%2,4802,480100.00%240,163Jun 30, 2024
SUMMITRY LLC0.00%0.01%2,2292,229100.00%215,857Jun 30, 2024
WEALTH ALLIANCE0.00%0.03%2,2032,203100.00%213,339Jun 30, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.0.00%0.00%2,1102,110100.00%204,000Jun 30, 2024
WALLEYE CAPITAL LLC0.00%0.00%900900100.00%87,156Jun 30, 2024
ANDRA AP-FONDEN0.00%0.00%800800100.00%106,040Jun 30, 2024
INTACT INVESTMENT MANAGEMENT INC.0.00%0.00%630630100.00%61,034Jun 30, 2024
0.00%0.03%510510100.00%49,388Jun 30, 2024
USA FINANCIAL PORTFORMULAS CORP0.00%0.01%368368100.00%35,637Jun 30, 2024
HHM WEALTH ADVISORS, LLC0.00%0.00%200200100.00%19,368Jun 30, 2024
BOKF, NA0.00%0.00%8585100.00%8,231Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP0.00%-4545100.00%4,358Jun 30, 2024
SMARTLEAF ASSET MANAGEMENT LLC-0.00%1818100.00%1,751Jun 30, 2024
FRAZIER FINANCIAL ADVISORS, LLC-0.00%1717100.00%1,647Jun 30, 2024
NATIXIS--1515100.00%1,453Jun 30, 2024

Design Therapeutics's largest new institutional shareholder by number of shares is CONGRESS ASSET MANAGEMENT CO /MA, purchased 1.22M shares, valued at $118.30M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUMITOMO MITSUI TRUST HOLDINGS, INC.----166,646-100.00%-Jun 30, 2024
MARYLAND STATE RETIREMENT & PENSION SYSTEM----57,628-100.00%-Jun 30, 2024
QUADRATURE CAPITAL LTD----42,000-100.00%-Jun 30, 2024
ALLIANZ ASSET MANAGEMENT GMBH----21,886-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----8,819-100.00%-Jun 30, 2024
BAROMETER CAPITAL MANAGEMENT INC.----7,800-100.00%-Jun 30, 2024
WOODLINE PARTNERS LP----6,785-100.00%-Jun 30, 2024
CAPSTONE INVESTMENT ADVISORS, LLC----6,178-100.00%-Jun 30, 2024
PORTFOLIO STRATEGIES, INC.----4,857-100.00%-Jun 30, 2024
MAVERICK CAPITAL LTD----4,721-100.00%-Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.----3,700-100.00%-Jun 30, 2024
QUANTBOT TECHNOLOGIES LP----3,165-100.00%-Jun 30, 2024
ARISTIDES CAPITAL LLC----2,875-100.00%-Jun 30, 2024
AXQ CAPITAL, LP----2,796-100.00%-Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----2,741-100.00%-Jun 30, 2024
GENUS CAPITAL MANAGEMENT INC.----2,640-100.00%-Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.----2,590-100.00%-Jun 30, 2024
XTX TOPCO LTD----2,535-100.00%-Jun 30, 2024
CERITY PARTNERS LLC----2,520-100.00%-Jun 30, 2024
FDX ADVISORS, INC.----2,482-100.00%-Jun 30, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND----2,230-100.00%-Jun 30, 2024
LINCOLN NATIONAL CORP----2,187-100.00%-Jun 30, 2024
SIMPLEX TRADING, LLC----1,985-100.00%-Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC----1,104-100.00%-Jun 30, 2024
BROWN BROTHERS HARRIMAN & CO----325-100.00%-Jun 30, 2024
CLARIVEST ASSET MANAGEMENT LLC----22-100.00%-Jun 30, 2024
HARBOUR INVESTMENTS, INC.----12-100.00%-Jun 30, 2024
FINANCIAL GRAVITY ASSET MANAGEMENT, INC.----11-100.00%-Jun 30, 2024

Design Therapeutics's largest sold out institutional shareholder by shares sold is SUMITOMO MITSUI TRUST HOLDINGS, INC., sold -0.17M shares, valued at -, as of undefined.

Design Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Brown Capital Management Mutual Funds0.70%2,099,248--Dec 31, 2023
ALLIED ASSET ADVISORS FUNDS0.57%6,400--Feb 29, 2024
TEKLA LIFE SCIENCES INVESTORS0.26%122,022--Mar 31, 2024
HARTFORD HLS SERIES FUND II INC0.19%46,300--Dec 31, 2023
TEKLA HEALTHCARE INVESTORS0.19%158,501--Mar 31, 2024
Vericimetry Funds0.13%11,35011,350-Mar 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.07%372,631--Mar 31, 2024
MARSICO INVESTMENT FUND0.07%91,600--Mar 31, 2024
BlackRock Health Sciences Trust II0.07%196,731--Mar 31, 2024
Cushing Mutual Funds Trust0.07%1,959--Aug 31, 2023
BRIDGEWAY FUNDS INC0.06%134,600--Mar 28, 2024
T. Rowe Price Health Sciences Fund, Inc.0.06%185,702--Mar 31, 2024
BlackRock Health Sciences Trust0.06%13,967--Mar 31, 2024
T. Rowe Price Small-Cap Value Fund, Inc.0.03%239,900--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.03%15,079--Mar 31, 2024
STATE STREET INSTITUTIONAL FUNDS0.02%17,086--Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.02%54,00718,63852.70%Feb 29, 2024
Humankind Benefit Corp0.02%374--Dec 31, 2023
FIDELITY SELECT PORTFOLIOS0.01%957,005--Feb 29, 2024
ETFis Series Trust I0.01%18,313--Jan 31, 2024
FIDELITY ADVISOR SERIES VII0.01%94,900--Jan 31, 2024
PFM Multi-Manager Series Trust0.01%8,029--Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.01%56,353--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%5,097--Mar 31, 2024
Fidelity Commonwealth Trust II0.01%42,29042,290-Aug 31, 2023
VICTORY PORTFOLIOS0.01%183,968--Mar 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.01%22,24413,071142.49%Mar 31, 2024
T. Rowe Price Equity Series, Inc.0.01%8,311--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%890--Mar 31, 2024
North Square Investments Trust0.00%36,932--Jan 31, 2024
MFS SERIES TRUST IV0.00%11,012--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%1,103,406-106,805-8.83%Mar 31, 2024
FIDELITY COVINGTON TRUST0.00%41,808-482-1.14%Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%26,451--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%74,915--Jan 31, 2024
DELAWARE GROUP GLOBAL & INTERNATIONAL FUNDS0.00%13,168--Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND IV0.00%4,311--Mar 31, 2024
Weiss Strategic Interval Fund0.00%5,0615,061-Sep 30, 2022
JANUS INVESTMENT FUND0.00%390,858--Dec 31, 2023
Direxion Shares ETF Trust0.00%190,720--Jan 31, 2024
Exchange Listed Funds Trust0.00%1,408--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%238,9644,8742.08%Feb 29, 2024
Calvert Variable Products, Inc.0.00%2,570--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%56,200--Feb 29, 2024
BLACKROCK ADVANTAGE GLOBAL FUND, INC.0.00%255--Mar 31, 2024
Arrow Investments Trust0.00%1,631--Jan 31, 2024
TARGET PORTFOLIO TRUST0.00%16,300--Jan 31, 2024
Principal Exchange-Traded Funds0.00%9,227-1,422-13.35%Mar 31, 2024
Forethought Variable Insurance Trust0.00%3,171--Mar 28, 2024
JOHN HANCOCK INVESTMENT TRUST0.00%62,560--Mar 31, 2024
HC CAPITAL TRUST0.00%24,003-4,265-15.09%Mar 31, 2024
PRINCIPAL VARIABLE CONTRACTS FUNDS INC0.00%26,100--Mar 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%64,253-2,500-3.75%Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%14,090--Mar 31, 2024
Virtus Investment Trust0.00%14,400--Mar 28, 2024
Capitol Series Trust0.00%4,000--Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%11,218--Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,688--Mar 31, 2024
Pear Tree Funds0.00%2,323--Mar 31, 2024
NORTHERN FUNDS0.00%37,204-2,253-5.71%Mar 28, 2024
NORTHWESTERN MUTUAL SERIES FUND INC0.00%27,200--Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%578--Mar 31, 2024
BlackRock ETF Trust0.00%183--Jan 31, 2024
SCHWAB STRATEGIC TRUST0.00%104,0153,9153.91%Feb 29, 2024
Federated Hermes Global Allocation Fund0.00%1,654--Feb 29, 2024
DFA INVESTMENT TRUST CO0.00%23,881--Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%9,700--Mar 31, 2024
Trust for Advised Portfolios0.00%2,664--Dec 31, 2023
BLACKROCK SUSTAINABLE BALANCED FUND, INC.0.00%922--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%2,33354830.70%Mar 31, 2024
AMERICAN CENTURY ETF TRUST0.00%9,4951,73522.36%Feb 29, 2024
MFS SERIES TRUST X0.00%809,086--Jan 31, 2024
EQ ADVISORS TRUST0.00%97,877--Mar 31, 2024
Forethought Variable Insurance Trust0.00%319--Mar 28, 2024
iSHARES TRUST0.00%1,195,206-72,686-5.73%Mar 31, 2024
RYDEX SERIES FUNDS0.00%299--Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS0.00%141,03614,82711.75%Feb 29, 2024
MUTUAL FUND SERIES TRUST0.00%281,569--Mar 31, 2024
THRIVENT SERIES FUND INC0.00%7,165--Mar 28, 2024
Voya INVESTORS TRUST0.00%3,437--Mar 31, 2024
SA FUNDS INVESTMENT TRUST0.00%1,007--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%6,6601141.74%Jan 31, 2024
PENN SERIES FUNDS INC0.00%1,300--Mar 28, 2024
TIAA-CREF FUNDS0.00%137,719--Jan 31, 2024
VALIC Co I0.00%12,576-51-0.40%Feb 29, 2024
Blackstone Alternative Investment Funds0.00%5,300-3,200-37.65%Mar 31, 2024
GOLDMAN SACHS TRUST0.00%131,94636,60938.40%Jan 31, 2024
RYDEX DYNAMIC FUNDS0.00%148--Dec 31, 2023
Virtus Strategy Trust0.00%728--Mar 28, 2024
ETF Series Solutions0.00%703--Jan 31, 2024
NORTHERN FUNDS0.00%4,127--Mar 28, 2024
VANGUARD WELLINGTON FUND0.00%11,162--Feb 29, 2024
Guggenheim Active Allocation Fund0.00%154--Feb 29, 2024
EMPOWER FUNDS, INC.0.00%26,303--Mar 31, 2024
Catholic Responsible Investments Funds0.00%796--Jan 31, 2023
ProFunds0.00%255-20-7.27%Mar 31, 2024
Dimensional ETF Trust0.00%8,648--Jan 31, 2024
TRUST FOR PROFESSIONAL MANAGERS0.00%6,080--Feb 29, 2024
PROSHARES TRUST0.00%4,801-3,000-38.46%Feb 29, 2024
USAA MUTUAL FUNDS TRUST0.00%4,35778822.08%Jan 31, 2024

Design Therapeutics's largest mutual fund holder by % of total assets is "Brown Capital Management Mutual Funds", owning 2.10M shares, compromising 0.70% of its total assets.

Design Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 243081.99%
31 Mar, 243025.96%
31 Dec, 2328512.65%
30 Sep, 23253-1.17%
30 Jun, 232561.19%
31 Mar, 2325311.45%
31 Dec, 222272.25%
30 Sep, 222222.78%
30 Jun, 22216-7.69%
31 Mar, 222344.00%
31 Dec, 2122510.29%
30 Sep, 212044.08%
30 Jun, 211965.38%
31 Mar, 21186-0.53%
31 Dec, 201873.89%
30 Sep, 201807.78%
30 Jun, 2016710.60%
31 Mar, 20151-3.82%
31 Dec, 191573.29%
30 Sep, 191522.01%
30 Jun, 1914912.88%
31 Mar, 191323.94%
31 Dec, 181272.42%
30 Sep, 181246.90%
30 Jun, 181165.45%
31 Mar, 181101.85%
31 Dec, 171081.89%
30 Sep, 171062.91%
30 Jun, 17103-0.96%
31 Mar, 171044.00%
31 Dec, 161004.17%
30 Sep, 16962.13%
30 Jun, 16941.08%
31 Mar, 1693-3.13%
31 Dec, 159611.63%
30 Sep, 15868.86%
30 Jun, 15795.33%
31 Mar, 157511.94%
31 Dec, 146715.52%
30 Sep, 1458-3.33%
30 Jun, 146020.00%
31 Mar, 14504.17%
31 Dec, 134829.73%
30 Sep, 133715.63%
30 Jun, 1332100.00%
31 Mar, 131614.29%
31 Dec, 1214-22.22%
30 Sep, 121828.57%
30 Jun, 121416.67%
31 Mar, 1212-20.00%
31 Dec, 111536.36%
30 Sep, 111110.00%
30 Jun, 111042.86%
31 Mar, 117-
31 Dec, 107-
30 Sep, 10740.00%
30 Jun, 105-16.67%
31 Mar, 106-
31 Dec, 096-45.45%
30 Sep, 0911175.00%
30 Jun, 094-
31 Mar, 094-
31 Dec, 084-33.33%
30 Sep, 086-25.00%
30 Jun, 088-11.11%
31 Mar, 08912.50%
31 Dec, 07814.29%
30 Sep, 077-12.50%
30 Jun, 078100.00%
31 Mar, 074-
31 Dec, 06433.33%
30 Sep, 063-
30 Jun, 063-40.00%
31 Mar, 065150.00%
31 Dec, 052100.00%
30 Sep, 051-66.67%
30 Jun, 053200.00%
31 Mar, 051-66.67%
31 Dec, 04350.00%
30 Sep, 042-50.00%
30 Jun, 04433.33%
31 Mar, 043-25.00%
31 Dec, 034-
30 Sep, 034-
30 Jun, 03433.33%
31 Mar, 033-25.00%
31 Dec, 024-20.00%
30 Sep, 025-16.67%
30 Jun, 02620.00%
31 Mar, 025150.00%
31 Dec, 012-
30 Sep, 012-66.67%
30 Jun, 016-14.29%
31 Mar, 01775.00%
31 Dec, 00433.33%
30 Sep, 003-
30 Jun, 003-25.00%
31 Mar, 004300.00%
31 Dec, 991-
30 Jun, 991-

As of 30 Jun 24, 308 institutions are holding Design Therapeutics's shares, representing an increase of 1.99% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2466,501,2852.04%
31 Mar, 2465,172,952-1.17%
31 Dec, 2365,944,5301.06%
30 Sep, 2365,252,690-1.58%
30 Jun, 2366,298,2810.22%
31 Mar, 2366,152,466-1.49%
31 Dec, 2267,153,162-3.18%
30 Sep, 2269,357,1721.69%
30 Jun, 2268,202,4522.41%
31 Mar, 2266,600,2884.45%
31 Dec, 2163,765,323-6.20%
30 Sep, 2167,978,6060.06%
30 Jun, 2167,938,8580.20%
31 Mar, 2167,802,479-1.29%
31 Dec, 2068,686,589-0.41%
30 Sep, 2068,969,101-0.01%
30 Jun, 2068,973,8071.46%
31 Mar, 2067,981,4091.28%
31 Dec, 1967,122,122-1.45%
30 Sep, 1968,109,482-3.41%
30 Jun, 1970,511,44311.88%
31 Mar, 1963,021,7910.91%
31 Dec, 1862,456,1471.47%
30 Sep, 1861,554,250-2.16%
30 Jun, 1862,913,0102.23%
31 Mar, 1861,539,7703.27%
31 Dec, 1759,590,776-0.56%
30 Sep, 1759,926,560-1.46%
30 Jun, 1760,812,6271.00%
31 Mar, 1760,209,1562.28%
31 Dec, 1658,867,094-2.56%
30 Sep, 1660,410,8751.67%
30 Jun, 1659,420,208-4.87%
31 Mar, 1662,463,492-1.56%
31 Dec, 1563,452,221-13.58%
30 Sep, 1573,426,96816.11%
30 Jun, 1563,240,067-2.16%
31 Mar, 1564,638,254-1.22%
31 Dec, 1465,433,27712.65%
30 Sep, 1458,087,907-3.45%
30 Jun, 1460,160,84432.99%
31 Mar, 1445,237,218-2.05%
31 Dec, 1346,185,9840.74%
30 Sep, 1345,847,85120.85%
30 Jun, 1337,939,31269.31%
31 Mar, 1322,408,15741.47%
31 Dec, 1215,839,339-24.91%
30 Sep, 1221,094,785-5.12%
30 Jun, 1222,233,88836.56%
31 Mar, 1216,281,14013.92%
31 Dec, 1114,291,95012.15%
30 Sep, 1112,743,24033.10%
30 Jun, 119,574,065118.20%
31 Mar, 114,387,79011.92%
31 Dec, 103,920,355-7.75%
30 Sep, 104,249,7472.30%
30 Jun, 104,154,372-8.53%
31 Mar, 104,541,972-45.34%
31 Dec, 098,309,876127.12%
30 Sep, 093,658,860-20.83%
30 Jun, 094,621,593-13.19%
31 Mar, 095,324,03926.13%
31 Dec, 084,221,100-46.15%
30 Sep, 087,838,000-45.16%
30 Jun, 0814,293,09083.66%
31 Mar, 087,782,20035.48%
31 Dec, 075,744,18426.69%
30 Sep, 074,534,000115.92%
30 Jun, 072,099,88557.76%
31 Mar, 071,331,100142.41%
31 Dec, 06549,1008.20%
30 Sep, 06507,500-8.98%
30 Jun, 06557,550-35.86%
31 Mar, 06869,30063.40%
31 Dec, 05532,000626.78%
30 Sep, 0573,200-25.38%
30 Jun, 0598,10034.02%
31 Mar, 0573,200-98.81%
31 Dec, 046,137,5901911.67%
30 Sep, 04305,100-94.82%
30 Jun, 045,891,3906666.50%
31 Mar, 0487,067-82.54%
31 Dec, 03498,7495.16%
30 Sep, 03474,295272.36%
30 Jun, 03127,375-69.97%
31 Mar, 03424,200-21.63%
31 Dec, 02541,275-7.03%
30 Sep, 02582,200-78.44%
30 Jun, 022,700,100906.66%
31 Mar, 02268,223-21.43%
31 Dec, 01341,400-47.05%
30 Sep, 01644,800-61.35%
30 Jun, 011,668,27098.32%
31 Mar, 01841,216-60.99%
31 Dec, 002,156,350-53.11%
30 Sep, 004,598,300147.89%
30 Jun, 001,854,97526.57%
31 Mar, 001,465,5251365.53%
31 Dec, 99100,000-
30 Jun, 99268,500-

Design Therapeutics (DSGN) has 66.50M shares outstanding as of 30 Jun 24, up 2.04% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 24117.73%868797.42%
31 Mar, 240.12%0.00%
31 Dec, 23117.78%0.87%
30 Sep, 23116.63%0.83%
30 Jun, 23118.58%0.85%
31 Mar, 23118.32%0.82%
31 Dec, 22120.21%0.78%
30 Sep, 22124.34%0.83%
30 Jun, 22122.51%0.85%
31 Mar, 22119.98%0.62%
31 Dec, 21138.81%0.91%
30 Sep, 21123.25%0.81%
30 Jun, 21123.34%0.78%
31 Mar, 21125.99%0.20%
31 Dec, 20252.59%0.39%
30 Sep, 20253.63%0.39%
30 Jun, 20253.65%0.41%
31 Mar, 20250.00%0.41%
31 Dec, 19246.84%0.39%
30 Sep, 19250.47%0.37%
30 Jun, 19259.30%0.48%
31 Mar, 19231.76%0.44%
31 Dec, 18229.68%0.45%
30 Sep, 18226.36%0.42%
30 Jun, 18231.36%0.45%
31 Mar, 18226.31%0.47%
31 Dec, 17219.14%0.45%
30 Sep, 17220.37%0.44%
30 Jun, 17223.63%0.46%
31 Mar, 17221.41%0.47%
31 Dec, 16216.48%0.44%
30 Sep, 16222.16%0.47%
30 Jun, 16218.51%0.41%
31 Mar, 16229.70%0.42%
31 Dec, 15233.34%0.32%
30 Sep, 15270.02%0.50%
30 Jun, 15232.56%0.41%
31 Mar, 15237.70%0.41%
31 Dec, 14240.63%0.53%
30 Sep, 14213.61%0.44%
30 Jun, 14221.24%0.80%
31 Mar, 14166.36%0.58%
31 Dec, 13169.84%0.60%
30 Sep, 13168.60%0.87%
30 Jun, 13139.52%2.05%
31 Mar, 1382.40%2.43%
31 Dec, 1258.25%0.97%
30 Sep, 1277.57%1.16%
30 Jun, 1281.76%2.28%
31 Mar, 1259.87%2.17%
31 Dec, 1152.56%2.39%
30 Sep, 1146.86%3.78%
30 Jun, 1135.21%13.52%
31 Mar, 1116.14%7.76%
31 Dec, 1014.42%5.90%
30 Sep, 1015.63%6.70%
30 Jun, 1015.28%5.48%
31 Mar, 1016.70%1.79%
31 Dec, 0930.56%16.88%
30 Sep, 0913.46%4.66%
30 Jun, 0917.00%4.43%
31 Mar, 0919.58%8.13%
31 Dec, 0815.52%1.87%
30 Sep, 0828.82%1.04%
30 Jun, 0852.56%6.42%
31 Mar, 0828.62%6.41%
31 Dec, 0721.12%7.60%
30 Sep, 0716.67%27.96%
30 Jun, 077.72%32.23%
31 Mar, 074.89%120.05%
31 Dec, 062.02%57.98%
30 Sep, 061.87%44.39%
30 Jun, 062.05%20.06%
31 Mar, 063.20%83.52%
31 Dec, 051.96%2699.78%
30 Sep, 050.27%206.82%
30 Jun, 050.36%497.85%
31 Mar, 050.27%0.05%
31 Dec, 0422.57%1792.93%
30 Sep, 041.12%0.24%
30 Jun, 0421.67%21132.10%
31 Mar, 040.32%9.52%
31 Dec, 031.83%60.29%
30 Sep, 031.74%794.96%
30 Jun, 030.47%19.25%
31 Mar, 031.56%39.37%
31 Dec, 021.99%43.42%
30 Sep, 022.14%2.17%
30 Jun, 029.93%1020.54%
31 Mar, 020.99%62.58%
31 Dec, 011.26%22.33%
30 Sep, 012.37%6.30%
30 Jun, 016.13%64.11%
31 Mar, 013.09%4.92%
31 Dec, 007.93%2.77%
30 Sep, 0016.91%36.34%
30 Jun, 006.82%23.49%
31 Mar, 005.39%3985.64%
31 Dec, 990.37%-
30 Jun, 990.99%-

As of 30 Jun 24, Design Therapeutics is held by 117.73% institutional shareholders, representing a 868797.42% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 241773.51%
31 Mar, 241714.91%
31 Dec, 2316342.98%
30 Sep, 23114-10.94%
30 Jun, 23128-9.22%
31 Mar, 2314150.00%
31 Dec, 2294-15.32%
30 Sep, 221117.77%
30 Jun, 22103-15.57%
31 Mar, 221222.52%
31 Dec, 2111922.68%
30 Sep, 2197-3.96%
30 Jun, 2110110.99%
31 Mar, 21912.25%
31 Dec, 2089-
30 Sep, 20897.23%
30 Jun, 208310.67%
31 Mar, 20757.14%
31 Dec, 1970-2.78%
30 Sep, 1972-19.10%
30 Jun, 198928.99%
31 Mar, 196911.29%
31 Dec, 186229.17%
30 Sep, 1848-12.73%
30 Jun, 185512.24%
31 Mar, 18494.26%
31 Dec, 17472.17%
30 Sep, 1746-6.12%
30 Jun, 1749-16.95%
31 Mar, 175937.21%
31 Dec, 164348.28%
30 Sep, 1629-17.14%
30 Jun, 1635-18.60%
31 Mar, 16432.38%
31 Dec, 1542-12.50%
30 Sep, 154833.33%
30 Jun, 1536-
31 Mar, 1536-16.28%
31 Dec, 144353.57%
30 Sep, 1428-15.15%
30 Jun, 143357.14%
31 Mar, 1421-22.22%
31 Dec, 132768.75%
30 Sep, 1316-36.00%
30 Jun, 1325257.14%
31 Mar, 13716.67%
31 Dec, 126-14.29%
30 Sep, 127-
30 Jun, 12740.00%
31 Mar, 125-50.00%
31 Dec, 111066.67%
30 Sep, 11650.00%
30 Jun, 114300.00%
31 Mar, 111-75.00%
31 Dec, 10433.33%
30 Sep, 10350.00%
30 Jun, 102-33.33%
31 Mar, 103-
31 Dec, 093-57.14%
30 Sep, 097-
30 Jun, 09--100.00%
31 Mar, 092-33.33%
31 Dec, 083-
30 Sep, 083-
30 Jun, 083-25.00%
31 Mar, 084-20.00%
31 Dec, 07525.00%
30 Sep, 074-33.33%
30 Jun, 076200.00%
31 Mar, 072-
31 Dec, 062-
30 Sep, 062-
30 Jun, 06--100.00%
31 Mar, 064300.00%
31 Dec, 051-
30 Sep, 05--100.00%
30 Jun, 052-
31 Mar, 05--100.00%
31 Dec, 041-
30 Sep, 041-75.00%
30 Jun, 044300.00%
31 Mar, 041-66.67%
31 Dec, 033200.00%
30 Sep, 031-50.00%
30 Jun, 032-
31 Mar, 03--100.00%
31 Dec, 022-
30 Sep, 022-50.00%
30 Jun, 02433.33%
31 Mar, 023-
31 Dec, 01--100.00%
30 Sep, 011-80.00%
30 Jun, 015-
31 Mar, 01525.00%
31 Dec, 00433.33%
30 Sep, 00350.00%
30 Jun, 002-50.00%
31 Mar, 004300.00%
31 Dec, 991-
30 Jun, 991-

177 institutional shareholders have increased their position in DSGN stock as of 30 Jun 24 compared to 171 in the previous quarter (a 3.51% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2490-8.16%
31 Mar, 24988.89%
31 Dec, 2390-13.46%
30 Sep, 2310413.04%
30 Jun, 239216.46%
31 Mar, 2379-22.55%
31 Dec, 2210234.21%
30 Sep, 2276-13.64%
30 Jun, 228814.29%
31 Mar, 2277-
31 Dec, 21775.48%
30 Sep, 21734.29%
30 Jun, 2170-5.41%
31 Mar, 2174-2.63%
31 Dec, 207611.76%
30 Sep, 2068-4.23%
30 Jun, 207114.52%
31 Mar, 20623.33%
31 Dec, 19603.45%
30 Sep, 195820.83%
30 Jun, 194814.29%
31 Mar, 1942-8.70%
31 Dec, 1846-8.00%
30 Sep, 185019.05%
30 Jun, 18425.00%
31 Mar, 18402.56%
31 Dec, 1739-2.50%
30 Sep, 174014.29%
30 Jun, 173520.69%
31 Mar, 1729-23.68%
31 Dec, 1638-11.63%
30 Sep, 164334.38%
30 Jun, 16323.23%
31 Mar, 1631-16.22%
31 Dec, 153768.18%
30 Sep, 1522-24.14%
30 Jun, 152916.00%
31 Mar, 1525108.33%
31 Dec, 1412-42.86%
30 Sep, 142131.25%
30 Jun, 1416-11.11%
31 Mar, 141828.57%
31 Dec, 131427.27%
30 Sep, 1311175.00%
30 Jun, 13433.33%
31 Mar, 133-
31 Dec, 123-25.00%
30 Sep, 12433.33%
30 Jun, 123-
31 Mar, 123200.00%
31 Dec, 111-
30 Sep, 111-66.67%
30 Jun, 113-
31 Mar, 11350.00%
31 Dec, 102-33.33%
30 Sep, 103200.00%
30 Jun, 101-50.00%
31 Mar, 102-
31 Dec, 092-33.33%
30 Sep, 093200.00%
30 Jun, 091-
31 Mar, 09--100.00%
31 Dec, 081-
30 Sep, 081-
30 Jun, 08--100.00%
31 Mar, 082100.00%
31 Dec, 071-
30 Sep, 071-
30 Jun, 07--
31 Mar, 07--
31 Dec, 06--
30 Sep, 06--100.00%
30 Jun, 063-
31 Mar, 06--
31 Dec, 05--
30 Sep, 05--
30 Jun, 05--100.00%
31 Mar, 051-
31 Dec, 04--
30 Sep, 04--
30 Jun, 04--100.00%
31 Mar, 042-
31 Dec, 03--100.00%
30 Sep, 032100.00%
30 Jun, 031-
31 Mar, 031-
31 Dec, 021-
30 Sep, 021-
30 Jun, 02--100.00%
31 Mar, 022-
31 Dec, 012-
30 Sep, 01--100.00%
30 Jun, 011-50.00%
31 Mar, 012-
31 Dec, 00--
30 Sep, 00--100.00%
30 Jun, 001-
31 Mar, 00--
31 Dec, 99--
30 Jun, 99--

90 institutional shareholders have reduced their position in DSGN stock as of 30 Jun 24 compared to 98 in the previous quarter (a -8.16% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 243081.99%66,501,2852.04%117.73%868797.42%1773.51%90-8.16%
31 Mar, 243025.96%65,172,952-1.17%0.12%0.00%1714.91%988.89%
31 Dec, 2328512.65%65,944,5301.06%117.78%0.87%16342.98%90-13.46%
30 Sep, 23253-1.17%65,252,690-1.58%116.63%0.83%114-10.94%10413.04%
30 Jun, 232561.19%66,298,2810.22%118.58%0.85%128-9.22%9216.46%
31 Mar, 2325311.45%66,152,466-1.49%118.32%0.82%14150.00%79-22.55%
31 Dec, 222272.25%67,153,162-3.18%120.21%0.78%94-15.32%10234.21%
30 Sep, 222222.78%69,357,1721.69%124.34%0.83%1117.77%76-13.64%
30 Jun, 22216-7.69%68,202,4522.41%122.51%0.85%103-15.57%8814.29%
31 Mar, 222344.00%66,600,2884.45%119.98%0.62%1222.52%77-
31 Dec, 2122510.29%63,765,323-6.20%138.81%0.91%11922.68%775.48%
30 Sep, 212044.08%67,978,6060.06%123.25%0.81%97-3.96%734.29%
30 Jun, 211965.38%67,938,8580.20%123.34%0.78%10110.99%70-5.41%
31 Mar, 21186-0.53%67,802,479-1.29%125.99%0.20%912.25%74-2.63%
31 Dec, 201873.89%68,686,589-0.41%252.59%0.39%89-7611.76%
30 Sep, 201807.78%68,969,101-0.01%253.63%0.39%897.23%68-4.23%
30 Jun, 2016710.60%68,973,8071.46%253.65%0.41%8310.67%7114.52%
31 Mar, 20151-3.82%67,981,4091.28%250.00%0.41%757.14%623.33%
31 Dec, 191573.29%67,122,122-1.45%246.84%0.39%70-2.78%603.45%
30 Sep, 191522.01%68,109,482-3.41%250.47%0.37%72-19.10%5820.83%
30 Jun, 1914912.88%70,511,44311.88%259.30%0.48%8928.99%4814.29%
31 Mar, 191323.94%63,021,7910.91%231.76%0.44%6911.29%42-8.70%
31 Dec, 181272.42%62,456,1471.47%229.68%0.45%6229.17%46-8.00%
30 Sep, 181246.90%61,554,250-2.16%226.36%0.42%48-12.73%5019.05%
30 Jun, 181165.45%62,913,0102.23%231.36%0.45%5512.24%425.00%
31 Mar, 181101.85%61,539,7703.27%226.31%0.47%494.26%402.56%
31 Dec, 171081.89%59,590,776-0.56%219.14%0.45%472.17%39-2.50%
30 Sep, 171062.91%59,926,560-1.46%220.37%0.44%46-6.12%4014.29%
30 Jun, 17103-0.96%60,812,6271.00%223.63%0.46%49-16.95%3520.69%
31 Mar, 171044.00%60,209,1562.28%221.41%0.47%5937.21%29-23.68%
31 Dec, 161004.17%58,867,094-2.56%216.48%0.44%4348.28%38-11.63%
30 Sep, 16962.13%60,410,8751.67%222.16%0.47%29-17.14%4334.38%
30 Jun, 16941.08%59,420,208-4.87%218.51%0.41%35-18.60%323.23%
31 Mar, 1693-3.13%62,463,492-1.56%229.70%0.42%432.38%31-16.22%
31 Dec, 159611.63%63,452,221-13.58%233.34%0.32%42-12.50%3768.18%
30 Sep, 15868.86%73,426,96816.11%270.02%0.50%4833.33%22-24.14%
30 Jun, 15795.33%63,240,067-2.16%232.56%0.41%36-2916.00%
31 Mar, 157511.94%64,638,254-1.22%237.70%0.41%36-16.28%25108.33%
31 Dec, 146715.52%65,433,27712.65%240.63%0.53%4353.57%12-42.86%
30 Sep, 1458-3.33%58,087,907-3.45%213.61%0.44%28-15.15%2131.25%
30 Jun, 146020.00%60,160,84432.99%221.24%0.80%3357.14%16-11.11%
31 Mar, 14504.17%45,237,218-2.05%166.36%0.58%21-22.22%1828.57%
31 Dec, 134829.73%46,185,9840.74%169.84%0.60%2768.75%1427.27%
30 Sep, 133715.63%45,847,85120.85%168.60%0.87%16-36.00%11175.00%
30 Jun, 1332100.00%37,939,31269.31%139.52%2.05%25257.14%433.33%
31 Mar, 131614.29%22,408,15741.47%82.40%2.43%716.67%3-
31 Dec, 1214-22.22%15,839,339-24.91%58.25%0.97%6-14.29%3-25.00%
30 Sep, 121828.57%21,094,785-5.12%77.57%1.16%7-433.33%
30 Jun, 121416.67%22,233,88836.56%81.76%2.28%740.00%3-
31 Mar, 1212-20.00%16,281,14013.92%59.87%2.17%5-50.00%3200.00%
31 Dec, 111536.36%14,291,95012.15%52.56%2.39%1066.67%1-
30 Sep, 111110.00%12,743,24033.10%46.86%3.78%650.00%1-66.67%
30 Jun, 111042.86%9,574,065118.20%35.21%13.52%4300.00%3-
31 Mar, 117-4,387,79011.92%16.14%7.76%1-75.00%350.00%
31 Dec, 107-3,920,355-7.75%14.42%5.90%433.33%2-33.33%
30 Sep, 10740.00%4,249,7472.30%15.63%6.70%350.00%3200.00%
30 Jun, 105-16.67%4,154,372-8.53%15.28%5.48%2-33.33%1-50.00%
31 Mar, 106-4,541,972-45.34%16.70%1.79%3-2-
31 Dec, 096-45.45%8,309,876127.12%30.56%16.88%3-57.14%2-33.33%
30 Sep, 0911175.00%3,658,860-20.83%13.46%4.66%7-3200.00%
30 Jun, 094-4,621,593-13.19%17.00%4.43%--100.00%1-
31 Mar, 094-5,324,03926.13%19.58%8.13%2-33.33%--100.00%
31 Dec, 084-33.33%4,221,100-46.15%15.52%1.87%3-1-
30 Sep, 086-25.00%7,838,000-45.16%28.82%1.04%3-1-
30 Jun, 088-11.11%14,293,09083.66%52.56%6.42%3-25.00%--100.00%
31 Mar, 08912.50%7,782,20035.48%28.62%6.41%4-20.00%2100.00%
31 Dec, 07814.29%5,744,18426.69%21.12%7.60%525.00%1-
30 Sep, 077-12.50%4,534,000115.92%16.67%27.96%4-33.33%1-
30 Jun, 078100.00%2,099,88557.76%7.72%32.23%6200.00%--
31 Mar, 074-1,331,100142.41%4.89%120.05%2---
31 Dec, 06433.33%549,1008.20%2.02%57.98%2---
30 Sep, 063-507,500-8.98%1.87%44.39%2---100.00%
30 Jun, 063-40.00%557,550-35.86%2.05%20.06%--100.00%3-
31 Mar, 065150.00%869,30063.40%3.20%83.52%4300.00%--
31 Dec, 052100.00%532,000626.78%1.96%2699.78%1---
30 Sep, 051-66.67%73,200-25.38%0.27%206.82%--100.00%--
30 Jun, 053200.00%98,10034.02%0.36%497.85%2---100.00%
31 Mar, 051-66.67%73,200-98.81%0.27%0.05%--100.00%1-
31 Dec, 04350.00%6,137,5901911.67%22.57%1792.93%1---
30 Sep, 042-50.00%305,100-94.82%1.12%0.24%1-75.00%--
30 Jun, 04433.33%5,891,3906666.50%21.67%21132.10%4300.00%--100.00%
31 Mar, 043-25.00%87,067-82.54%0.32%9.52%1-66.67%2-
31 Dec, 034-498,7495.16%1.83%60.29%3200.00%--100.00%
30 Sep, 034-474,295272.36%1.74%794.96%1-50.00%2100.00%
30 Jun, 03433.33%127,375-69.97%0.47%19.25%2-1-
31 Mar, 033-25.00%424,200-21.63%1.56%39.37%--100.00%1-
31 Dec, 024-20.00%541,275-7.03%1.99%43.42%2-1-
30 Sep, 025-16.67%582,200-78.44%2.14%2.17%2-50.00%1-
30 Jun, 02620.00%2,700,100906.66%9.93%1020.54%433.33%--100.00%
31 Mar, 025150.00%268,223-21.43%0.99%62.58%3-2-
31 Dec, 012-341,400-47.05%1.26%22.33%--100.00%2-
30 Sep, 012-66.67%644,800-61.35%2.37%6.30%1-80.00%--100.00%
30 Jun, 016-14.29%1,668,27098.32%6.13%64.11%5-1-50.00%
31 Mar, 01775.00%841,216-60.99%3.09%4.92%525.00%2-
31 Dec, 00433.33%2,156,350-53.11%7.93%2.77%433.33%--
30 Sep, 003-4,598,300147.89%16.91%36.34%350.00%--100.00%
30 Jun, 003-25.00%1,854,97526.57%6.82%23.49%2-50.00%1-
31 Mar, 004300.00%1,465,5251365.53%5.39%3985.64%4300.00%--
31 Dec, 991-100,000-0.37%-1---
30 Jun, 991-268,500-0.99%-1---

Design Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 12, 2024William Arsanidirector-S-SaleSell814,874$4.25$3.46M-
Mar 25, 2024Schmid John P.director-P-PurchaseBuy17,809$3.74$66.61K26,965
Mar 25, 2024Schmid John P.director-P-PurchaseBuy9,156$3.62$33.13K9,156
Mar 25, 2024Berger Heather A.director-P-PurchaseBuy1,300$3.74$4.87K1,300
Oct 02, 2023LAPPE RODNEY Wdirector-P-PurchaseBuy21,000$2.35$49.29K133,024

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 25, 2024Schmid John P.director-P-PurchaseBuy17,809$3.74$66.61K26,965
Mar 25, 2024Schmid John P.director-P-PurchaseBuy9,156$3.62$33.13K9,156
Mar 25, 2024Berger Heather A.director-P-PurchaseBuy1,300$3.74$4.87K1,300
Oct 02, 2023LAPPE RODNEY Wdirector-P-PurchaseBuy21,000$2.35$49.29K133,024

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 12, 2024William Arsanidirector-S-SaleSell814,874$4.25$3.46M-
Mar 20, 2024Kim Jae B.officer Chief Medical OfficerSell---4,756
Mar 20, 2024Kim Jae B.officer Chief Medical OfficerSell315,000$12.77$4.02M-
Mar 20, 2024Kim Jae B.officer Chief Medical OfficerSell115,000$7.97$916.55K-
Mar 20, 2024Kim Jae B.officer Chief Medical OfficerSell175,000$2.54$444.50K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 12, 2024William Arsanidirector-S-SaleSell814,874$4.25$3.46M-
Jun 17, 2024George Simeondirector, 10 percent owner A-AwardBuy19,000$3.82$72.58K19,000
Jun 17, 2024William Arsanidirector-A-AwardBuy19,000$3.82$72.58K19,000
Jun 17, 2024LAPPE RODNEY Wdirector-A-AwardBuy19,000$3.82$72.58K19,000
Jun 17, 2024Schmid John P.director-A-AwardBuy19,000$3.82$72.58K19,000
Jun 17, 2024Berger Heather A.director-A-AwardBuy19,000$3.82$72.58K19,000
Jun 17, 2024Prasad Deepadirector-A-AwardBuy19,000$3.82$72.58K19,000
Mar 25, 2024Schmid John P.director-P-PurchaseBuy17,809$3.74$66.61K26,965
Mar 25, 2024Schmid John P.director-P-PurchaseBuy9,156$3.62$33.13K9,156
Mar 25, 2024Berger Heather A.director-P-PurchaseBuy1,300$3.74$4.87K1,300
Mar 20, 2024Kim Jae B.officer Chief Medical OfficerSell---4,756
Mar 20, 2024Kim Jae B.officer Chief Medical OfficerSell315,000$12.77$4.02M-
Mar 20, 2024Kim Jae B.officer Chief Medical OfficerSell115,000$7.97$916.55K-
Mar 20, 2024Kim Jae B.officer Chief Medical OfficerSell175,000$2.54$444.50K-
Jan 05, 2024Burgess Julieofficer Chief Accounting OfficerA-AwardBuy110,000$2.54$279.40K110,000
Jan 05, 2024Jeffries Seanofficer Chief Operating OfficerA-AwardBuy350,000$2.54$889.00K350,000
Dec 05, 2023LAPPE RODNEY Wdirector-A-AwardBuy69,186$2.51$173.66K69,186
Dec 05, 2023Ansari Aseem Z.10 percent owner-A-AwardBuy100,000$2.51$251.00K100,000
Oct 02, 2023LAPPE RODNEY Wdirector-P-PurchaseBuy21,000$2.35$49.29K133,024
Sep 06, 2023William Arsanidirector-C-ConversionBuy1,217,627--1,217,627

The last insider sell of Design Therapeutics's stock was made by William Arsani on Aug 12 2024, selling 814,874 shares at $4.25 per share (valued at $3.46M). The last insider buy of DSGN was made by Schmid John P. on Mar 25 2024, buying 17,809 shares at $3.74 per share (worth $66.61K).

Design Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 202454125.00%
Q4 20232--
Q3 20236--
Q2 20237--
Q1 20234--
Q4 20229--
Q2 20229--
Q1 202261600.00%
Q4 20211--
Q3 20211250.00%
Q2 20212--
Q1 20213124129.17%
Q4 2020-1-

5 total buy trades, and 4 total sell trades (buy/sell ratio of 1.25%) were made by Design Therapeutics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 20243--
Q4 2023---
Q3 20234--
Q2 2023---
Q1 2023---
Q4 20229--
Q2 2022---
Q1 202211100.00%
Q4 2021---
Q3 20211--
Q2 2021---
Q1 202110--
Q4 2020---

As of Q1 2024, Insider owners conducted 3 open market buy trades and 0 open market sell trades of Design Therapeutics's stocks.

Design Therapeutics Peer Ownership


TickerCompany
GRCLGracell Biotechnologies Inc.
MGTADianthus Therapeutics, Inc.
CGEMCullinan Oncology, Inc.
ACHLAchilles Therapeutics plc
ADCTADC Therapeutics SA
IKNAIkena Oncology, Inc.
STOKStoke Therapeutics, Inc.
IMCRImmunocore Holdings plc
ERASErasca, Inc.
ALXOALX Oncology Holdings Inc.
GRPHLENZ Therapeutics, Inc.
ALVRAlloVir, Inc.
CCCCC4 Therapeutics, Inc.
GLUEMonte Rosa Therapeutics, Inc.
HOWLWerewolf Therapeutics, Inc.
NLTXNeurogene Inc.
AADIAadi Bioscience, Inc.

DSGN Ownership FAQ


Design Therapeutics is owned by institutional shareholders (117.73%), insiders (36.45%), and public (-54.18%). The largest institutional shareholder of Design Therapeutics is PRICE T ROWE ASSOCIATES INC /MD/ (12.90% of total shares) and the top mutual fund owner is Brown Capital Management Mutual Funds (0.70% of total shares).

Design Therapeutics's major institutional shareholders are PRICE T ROWE ASSOCIATES INC /MD/, DURABLE CAPITAL PARTNERS LP, VANGUARD GROUP INC, CONESTOGA CAPITAL ADVISORS, LLC, and JARISLOWSKY, FRASER LTD. The top five shareholders own together 35.31% of the company's share outstanding.

As of Jun 2024, there are 308 institutional shareholders of Design Therapeutics.

PRICE T ROWE ASSOCIATES INC /MD/ owns 7.29M shares of Design Therapeutics, representing 12.90% of the company's total shares outstanding, valued at $705.9M (as of Jun 2024).

As of Jun 2024, DURABLE CAPITAL PARTNERS LP holds 3.46M shares of Design Therapeutics (DSGN), compromising 6.12% of the company, valued at $334.67M.

VANGUARD GROUP INC is the third largest holder of Design Therapeutics. The company owns 3.19M of the company's shares outstanding (worth $309.29M).